Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CIFENLINE for Hypertrophic cardiomyopathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where CIFENLINE was used for Hypertrophic cardiomyopathy.

Most Reported Side Effects for CIFENLINE

Side Effect Reports % Deaths Hosp.
Hypoglycaemia 10 13.9% 1 7
Arrhythmia 7 9.7% 2 4
Orthostatic hypotension 7 9.7% 0 6
Cardiac failure 6 8.3% 0 5
Hepatocellular injury 6 8.3% 0 6
Altered state of consciousness 5 6.9% 1 2
Cholestasis 5 6.9% 0 5
Condition aggravated 5 6.9% 1 4
Hepatitis acute 5 6.9% 0 5
Interstitial lung disease 5 6.9% 2 4

Other Indications for CIFENLINE

Product used for unknown indication (22) Atrial fibrillation (17) Arrhythmia (10)

Other Drugs Used for Hypertrophic cardiomyopathy

MAVACAMTEN (2,708) METOPROLOL (96) DISOPYRAMIDE (93) VERAPAMIL (85) PROPRANOLOL (50) BISOPROLOL (42) FUROSEMIDE (37) AMIODARONE (26) DILTIAZEM (20) SACUBITRIL\VALSARTAN (18)

Related Pages

CIFENLINE Full Profile All Hypertrophic cardiomyopathy Drugs CIFENLINE Demographics CIFENLINE Timeline